Is infertility more common among patients with multiple sclerosis? Implications for utilization of assisted reproductive techniques

被引:0
作者
Skvirsky, Sivan [1 ,2 ]
Winer, Zofnat Magnezi [1 ,2 ]
Baratz, Shirly Lahav [1 ,2 ]
Barsha, Hanin [1 ,2 ]
Younes, Grace [1 ,2 ]
Miller, Ariel [3 ]
Oron, Galia [1 ,2 ]
机构
[1] Technion, Rappaport Fac Med, Lady Davis Carmel Med Ctr, Dept Obstet & Gynecol, Haifa, Israel
[2] Div Reprod Ctr, Haifa, Israel
[3] Israel Inst Technol, Multiple Sclerosis Ctr, Carmel Med Ctr & Technion, Dept Neurol, Haifa, Israel
关键词
Assisted reproductive technology; Infertility; IVF; Multiple sclerosis; Ovarian stimulation; ANTI-MULLERIAN HORMONE; SEXUAL DYSFUNCTION; WOMEN; PREGNANCY; MANAGEMENT; BIOMARKER; ISSUES; GENDER;
D O I
10.1016/j.rbmo.2024.103980
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Research question: Is fertility affected in women with multiple sclerosis (MS), and what is their usage of assisted reproductive technology (ART)? Design: Data regarding multiple sclerosis and ART usage among patients with multiple sclerosis were extracted from the Israeli health maintenance organization Clalit Health Service database. Data regarding the diagnosis and treatment of multiple sclerosis, cause of infertility and use of fertility treatments were collected for all female multiple sclerosis patients aged 18-45 years between 2005 and 2021. Each patient was matched by age in a 1:10 ratio with reference women from the general population. The prevalence of infertility was compared between the two groups. Univariate and multivariate statistical tests were used to analyse the association between multiple sclerosis and fertility treatments including IVF and ovarian stimulation. Results: During the study period, 1309 multiple sclerosis patients were compared with 13,090 controls from the general population matched for age. The mean age was 29 7.8 years. The overall prevalence of infertility was 15.4% (202/1309) among the multiple sclerosis patients, similar to the general population (16.3%; 2129/13090) (P = 0.436). The prevalence of IVF and ovarian stimulation was similar among multiple sclerosis patients and matched controls from the general population (8.1% versus 7.2%, P = 0.240; 13.8% versus 14.3%; P = 0.624, respectively). Conclusions: The results show similar rates of infertility and fertility treatments among multiple sclerosis patients and the general population. This provides reassurance that fertility among women with multiple sclerosis does not differ from that of women in the general population, and indicates there is no excessive usage of ART.
引用
收藏
页数:7
相关论文
共 34 条
  • [1] Fertility, Pregnancy and Childbirth in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs
    Amato, Maria Pia
    Portaccio, Emilio
    [J]. CNS DRUGS, 2015, 29 (03) : 207 - 220
  • [2] [Anonymous], 2019, Obstet Gynecol, V133, pe377, DOI 10.1097/AOG.0000000000003271
  • [3] Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimullerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection
    Arce, Joan-Carles
    Andersen, Anders Nyboe
    Fernandez-Sanchez, Manuel
    Visnova, Hana
    Bosch, Ernesto
    Garcia-Velasco, Juan Antonio
    Barri, Pedro
    de Sutter, Petra
    Klein, Bjarke M.
    Fauser, Bart C. J. M.
    [J]. FERTILITY AND STERILITY, 2014, 102 (06) : 1633 - U456
  • [4] Investigating the interaction between fertility, pregnancy, and multiple sclerosis
    Ashtari, Freshteh
    Mokhtari, Fatemeh
    Valiani, Mahboubeh
    Soudavi, Mohammad
    Saadat, Homa
    Tolouei, Hamidreza
    Mansourian, Marjan
    [J]. JOURNAL OF EDUCATION AND HEALTH PROMOTION, 2021, 10 (01)
  • [5] Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy
    Nadja Borisow
    Andrea Döring
    Caspar F Pfueller
    Friedemann Paul
    Jan Dörr
    Kerstin Hellwig
    [J]. EPMA Journal, 2012, 3 (1) : 9
  • [6] The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis
    Bove, Riley
    Chitnis, Tanuja
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (05) : 520 - 526
  • [7] Bove Riley M, 2022, Continuum (Minneap Minn), V28, P12, DOI 10.1212/CON.0000000000001108
  • [8] Calabresi PA, 2004, AM FAM PHYSICIAN, V70, P1935
  • [9] Pregnancy-related issues in women with multiple sclerosis: an evidence-based review with practical recommendations
    Canibano, Beatriz
    Deleu, Dirk
    Mesraoua, Boulenouar
    Melikyan, Gayane
    Ibrahim, Faiza
    Hanssens, Yolande
    [J]. JOURNAL OF DRUG ASSESSMENT, 2020, 9 (01) : 20 - 36
  • [10] Management of women with multiple sclerosis through pregnancy and after childbirth
    Coyle, Patricia K.
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2016, 9 (03) : 198 - 210